Pharmacokinetic-Pharmacodynamic and Pharmacogenetic Studies of Flavopiridol and its Glucuronide Metabolite

Pharmacokinetic-Pharmacodynamic and Pharmacogenetic Studies of Flavopiridol and its Glucuronide Metabolite

Bibliographic Details
Main Author:	Ni, Wenjun
Language:	English
Published:	The Ohio State University / OhioLINK 2011
Subjects:	Pharmaceuticals Pharmacy Sciences Chronic lymphocytic leukemia cyclin-dependent kinase inhibitor pharmacokinetics pharmacodynamics pharmacogenetics drug transporters OATP1B1 glutathionep
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1299680524

Similar Items

Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin
by: Samineni, Divya
Published: (2011)

Population pharmacokinetics and pharmacodynamics of pyronaridine
by: Methaneethorn, Janthima
Published: (2013)

Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal Cancer
by: Apostolos Papachristos, et al.
Published: (2020-05-01)

Pharmacogenetics of carbamazepine
by: N. A. Shnayder, et al.
Published: (2020-01-01)

Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole
by: Dave, Nimita D.
Published: (2013)

Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P1 Receptor Modulator in Healthy Subjects
by: Pierre-Eric Juif, et al.
Published: (2017-12-01)

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study
by: Sabrina Falkowski, et al.
Published: (2017-12-01)

Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c.388A>G Variant Is Determinant of Increased Atorvastatin Response
by: Rosario D. C. Hirata, et al.
Published: (2011-09-01)

Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies
by: Zachary L. Taylor, et al.
Published: (2021-06-01)

Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers
by: Shijia Liu, et al.
Published: (2017-07-01)

Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M.
by: Viljoen, Michelle
Published: (2012)

Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M.
by: Viljoen, Michelle
Published: (2012)

Using Pharmacokinetic and Pharmacodynamic Principles to Evaluate Individualisation of Antibiotic Dosing – Emphasis on Cefuroxime
by: Viberg, Anders
Published: (2006)

Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy
by: Jin Lu, et al.
Published: (2020-06-01)

Evaluating Pharmacokinetic and Pharmacodynamic Interactions with Computational Models in Supporting Cumulative Risk Assessment
by: Jerry Campbell, et al.
Published: (2011-05-01)

Pharmacokinetics and Pharmacogenetics of Apixaban
by: A. V. Savinova, et al.
Published: (2020-11-01)

Mechanisms of development of antipsychotic-induced metabolic disorders: pharmacogenetic aspect
by: R. F. Nasyrova, et al.
Published: (2018-01-01)

Sulodexide. Pharmacokinetics, pharmacodynamics, and mechanism of action
by: Luca Masotti
Published: (2015-10-01)

Cefazolin in dog: preliminary results for pharmacokinetic and pharmacodynamic parameters
by: Federica Di Cesare
Published: (2016-06-01)

Analysis and pharmacokinetics of morphine and morphine-6-glucuronide
by: Chapman, David John
Published: (1990)

Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs
by: Poonavit Pichayapaiboon, et al.
Published: (2021-08-01)

Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facility
by: Saldivar JS, et al.
Published: (2016-01-01)

Pharmacokinetic–Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats
by: Dong-Seok Lee, et al.
Published: (2018-04-01)

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
by: Dawed AY, et al.
Published: (2016-04-01)

Pharmacodynamics and pharmacokinetics of snake antivenom
by: Bhagya Nikapitiya, et al.
Published: (2018-06-01)

Mechanism-Based Pharmacokinetic and Pharmacodynamic Modelling of Paclitaxel
by: Henningsson, Anja
Published: (2005)

Pharmacodynamics of Five Anthraquinones (Aloe-emodin, Emodin, Rhein, Chysophanol, and Physcion) and Reciprocal Pharmacokinetic Interaction in Rats with Cerebral Ischemia
by: Rong-Rong Li, et al.
Published: (2019-05-01)

Nanomedicine: pharmacological perspectives
by: Bhattacharya Santanu, et al.
Published: (2012-06-01)

Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects
by: Bi, Youwei
Published: (2016)

Pharmacokinetic profile and some pharmacodynamic aspects of cefquinome in chickens
by: A. A. M. El-Gendy, et al.
Published: (2009-12-01)

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
by: Bouazza Naïm, et al.
Published: (2011-12-01)

The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers
by: Guojing Liu, et al.
Published: (2016-12-01)

Pharmacokinetic and pharmacodynamic correlation of plasma concentrations and blood pressure in hypertensive patients: A study
by: Mahvash Iram, et al.
Published: (2016-01-01)

Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury
by: Jianbin Min, et al.
Published: (2018-09-01)

Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients
by: Jemal Hussien Ahmed, et al.
Published: (2020-04-01)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
by: Raghunandan Reddy Kura, et al.
Published: (2018-05-01)

Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses
by: Anthoney D, et al.
Published: (2012-11-01)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Lien Thi Ngo, et al.
Published: (2020-10-01)

An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
by: Eric Wenzler, et al.
Published: (2020-10-01)

COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: O. P. Bobrova, et al.
Published: (2015-12-01)